DRC Gyógyszervizsgáló Központ

Balatonfüred, Veszprém megye 8230

0 studies enrolling now · 7 studies all time

What they study most

Cardiovascular Diseases, Crohn's Disease, Diabetes Mellitus, Obesity, Obstructive Sleep Apnea, Osteoarthritis, Knee, Overweight, Overweight and Obesity, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease — Completed
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes — Completed
• A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight — Completed
• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling
• A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin — Completed
• Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity — Stopped early
• A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities — Completed